טוען...
ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study
BACKGROUND: Hospitalized patients usually have significant comorbidities and receive multiple medications which leads to a high frequency of contraindications to standard treatment options for acute gout (NSAIDs, colchicine, steroids). Adrenocorticotropic hormone (ACTH) has long been used in acute g...
שמור ב:
| הוצא לאור ב: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Mediterranean Journal of Rheumatology (MJR)
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046044/ https://ncbi.nlm.nih.gov/pubmed/32185321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.29.3.178 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|